Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nelly Siller"'
Autor:
Wolf A Lagrèze, Sebastian Küchlin, Gabriele Ihorst, Birgit Grotejohann, Flemming Beisse, Martin Volkmann, Sven P Heinrich, Philipp Albrecht, Judith Ungewiss, Michael Wörner, Martin J Hug, Sebastian Wolf, Ricarda Diem, Orhan Aktas, Anna Beck, Anke Beckmann, Achim Berthele, Lena Bönig, Heike Elflein, Dirk Fitzner, Vinzenz Fleischer, Stefan Gingele, Tanja Guthoff, Rainer Guthoff, Kathrin Hartmann, Andrea Hassenstein, Christoph Heesen, Katharina Hein, Sven P. Heinrich, Karsten Hufendiek, Martin J. Hug, Konstantin Huhn, Martin W. Hümmert, Matthias Klopfer, Friedrich E. Kruse, Tania Kümpfel, Wolf A. Lagrèze, Ralf A. Linker, Katrin Lorenz, Fanni E. Molnár, Elisabeth Mulazzani, Marcus Müller, Florian T. Nickel, Marion Noll, Amelie Pielen, Susanne Pitz, Sebastian Rauer, Michael Reich, Sina Rosenkranz, Philipp Schwenkenbecher, Nelly Siller, Thomas Skripuletz, Martin Stangel, Jan-Patrick Stellmann, Klarissa Stürner, Kurt-Wolfram Sühs, Timo Uphaus, Christian van Oterendorp, Bettina Wabbels, Helmut Wilhelm, Ulf Ziemann, Frauke Zipp
Publikováno v:
The Lancet. Neurology. 20(12)
Summary Background The human cytokine erythropoietin conveys neuroprotection in animal models but has shown ambiguous results in phase 2 clinical trials in patients with optic neuritis. We assessed the safety and efficacy of erythropoietin in patient
Publikováno v:
Expert Review of Neurotherapeutics. 18:203-219
Approved medications for relapsing-remitting multiple sclerosis have shown to be effective in terms of their anti-inflammatory potential. However, it is also crucial to evaluate what long-term effects a patient can expect from current MS drugs in ter
Autor:
Hubert J. Bardenheuer, Gerd Mikus, Nelly Siller, Marcus J. P. Geist, Juergen Burhenne, Gerlinde Egerer
Publikováno v:
Basic & Clinical Pharmacology & Toxicology.
Cytochrome P450 3A (CYP3A) is the most relevant drug-metabolizing enzyme in human beings involved in the elimination of about 50% of the marketed drugs. Comprehensive in vivo data of CYP3A activity in palliative patients with haematological diseases
Autor:
Jan S. Kirschke, Reinhard Hohlfeld, Janine Schultz, Gisela Antony, Ralf Gold, Philipp G. Sämann, Tania Kümpfel, Felix Luessi, Ralf A. Linker, Anke Salmen, Christiane Graetz, Uwe K. Zettl, Gerrit Toenges, Mark Mühlau, Vinzenz Fleischer, Joachim Havla, Viola Biberacher, Bernhard Hemmer, Carmen Infante-Duarte, Antje Jahn-Eimermacher, Achim Berthele, Michael Hecker, Steffen Pfeuffer, F. Weber, Nelly Siller, Adriane Gröger, Heinz Wiendl, Carsten Lukas, Frauke Zipp, Christina M. Lill, Sergiu Groppa, Daniela Zöller, Friedemann Paul, Barbara Bellenberg
Background: The course of multiple sclerosis (MS) shows substantial inter-individual variability. The underlying determinants of disease severity likely involve genetic and environmental factors. Objective: The aim of this study was to assess the imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d65e1725c0825ac91b1b59be73f578
https://opus4.kobv.de/opus4-fau/files/13836/10.1177_1352458518763541.pdf
https://opus4.kobv.de/opus4-fau/files/13836/10.1177_1352458518763541.pdf
Autor:
Ludwig Kappos, Timo Uphaus, Stefan Bittner, Frauke Zipp, Sergiu Groppa, Nelly Siller, Christian Barro, Jens Kuhle, Muthuraman Muthuraman
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 25(5)
Background: Monitoring neuronal injury remains one key challenge in early relapsing-remitting multiple sclerosis (RRMS) patients. Upon axonal damage, neurofilament – a major component of the neuro-axonal cytoskeleton – is released into the cerebr
Autor:
Harmandeep Kaur, Florian C. Kurschus, Frauke Zipp, Stefan Günther, Daniel Staudenraus, Myriam Grimm, Denise Tischner, Florian Wanke, Stefan Offermanns, Ari Waisman, Nicholas Schwab, Sonja Moos, Johanna Breuer, Nelly Siller, Jorge Carvalho, Nina Wettschureck, Mario Looso
Publikováno v:
JCI insight. 2(15)
GPCR expression was intensively studied in bulk cDNA of leukocyte populations, but limited data are available with respect to expression in individual cells. Here, we show a microfluidic-based single-cell GPCR expression analysis in primary T cells,
Publikováno v:
Annals of Hematology. 93:1941-1942
Dear Editor, Treatment with all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy is currently the approved standard of care for primary acute promyelocytic leukemia (APL) [1]. Recently, treatment with arsenic trioxide (ATO) and ATRA pr
Publikováno v:
Archives of Toxicology. 88:179-180
Autor:
Küchlin, Sebastian, Ihorst, Gabriele, Grotejohann, Birgit, Beisse, Flemming, Heinrich, Sven P., Albrecht, Philipp, Ungewiss, Judith, Wörner, Michael, Hug, Martin J., Wolf, Sebastian, Diem, Ricarda, Lagrèze, Wolf A.
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation; Jul2023, Vol. 10 Issue 4, p1-10, 10p
Autor:
Geist, Marcus J. P.1 (AUTHOR) marcus.geist@med.uni-heidelberg.de, Siller, Nelly2 (AUTHOR), Egerer, Gerlinde3 (AUTHOR), Bardenheuer, Hubert1 (AUTHOR), Burhenne, Juergen2 (AUTHOR), Mikus, Gerd2 (AUTHOR)
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. Aug2019, Vol. 125 Issue 2, p117-122. 6p.